MesoCoat Moves to New Facility in Ohio

MesoCoat, subsidiary of Abakan, has moved into a new metal cladding and spray coating facility in Eastlake, Ohio.

The facility integrates thermal spray coating cells for PComP and two metal cladding lines for CermaClad. In addition, the Eastlake plant houses a metallurgical and analytical laboratory. The new 10,000 sq ft. facility will be the company’s fourth facility in the region. MesoCoat already operates two facilities in Ohio and the third plant is under construction.

The Eastlake facility is mainly established for cladding plates and parts for the shipbuilding and oil and gas industries and also to offer thermal spray coating materials to mining and oil and gas sectors in the U.S.

MesoCoat will install a 600 kW cladding arc lamp system at the facility. The system is purchased from an international heavy equipment manufacturer and it will be used to develop cladding products that are resistant to wear and corrosion. MesoCoat has been utilizing 200 kW fusion arc lamp systems to create metallurgically clad samples, which produces excellent results. The new 600 kW system produces better results and accelerates MesoCoat’s production initiatives. MesoCoat also expects to purchase two additional 500kW arc lamp cladding systems in 2012.

Source: http://www.abakaninc.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 09). MesoCoat Moves to New Facility in Ohio. AZoM. Retrieved on April 26, 2024 from https://www.azom.com/news.aspx?newsID=30576.

  • MLA

    Chai, Cameron. "MesoCoat Moves to New Facility in Ohio". AZoM. 26 April 2024. <https://www.azom.com/news.aspx?newsID=30576>.

  • Chicago

    Chai, Cameron. "MesoCoat Moves to New Facility in Ohio". AZoM. https://www.azom.com/news.aspx?newsID=30576. (accessed April 26, 2024).

  • Harvard

    Chai, Cameron. 2019. MesoCoat Moves to New Facility in Ohio. AZoM, viewed 26 April 2024, https://www.azom.com/news.aspx?newsID=30576.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.